Mildex Optical eyes new revenue from pet biosensor chip with mass production slated in 2H26

▤ Summary

Mildex Optical has started clinical testing of a pet degenerative arthritis biosensor in Taiwan. The company plans to move toward mass production in the second half of 2026. The device could expand point-of-care diagnostics for animal care markets worldwide. This looks like an early commercialization step rather than a finished software product announcement.

▦ Linked Companies